Unlock instant, AI-driven research and patent intelligence for your innovation.

Resistance marker-free porcine actinobacillus pleuropneumoniae double-gene defective strain, construction method and application thereof

A technology of porcine pleuropneumonia and actinobacillus, applied in the field of bacterial genetic engineering, can solve the problems of being unable to prevent lung lesions and chronic infections, and the inability to provide cross-protection for infection of heterologous serotypes, and achieve the effect of broad market application prospects

Inactive Publication Date: 2013-07-31
HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The currently used whole-bacteria inactivated vaccines and subunit vaccines can alleviate the clinical symptoms and reduce the mortality caused by homologous serotype infection pigs, but they cannot prevent lung lesions and chronic infection, and cannot provide a good response to heterologous serotype infection. Good cross-protection, while natural or experimental infection can induce protection against any heterologous serotype

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Resistance marker-free porcine actinobacillus pleuropneumoniae double-gene defective strain, construction method and application thereof
  • Resistance marker-free porcine actinobacillus pleuropneumoniae double-gene defective strain, construction method and application thereof
  • Resistance marker-free porcine actinobacillus pleuropneumoniae double-gene defective strain, construction method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0070] Example 1 Construction of APP Serum Type 7 clpP Single Gene Deletion Mutant

[0071] 1.1 Construction of recombinant suicide vector pUCΔclpP

[0072] 1.1.1 Primer design and PCR amplification of the upper and lower homology arms of the ClpP protease gene

[0073] According to the reported sequence of APP-7 AP76 strain (refer to the gene sequence of GenBank accession number CP001091.1), two pairs of primers were designed to amplify the upper homology arm ClpPS and the lower homology arm ClpPX of the clpP gene respectively, and the size of the amplified fragment was For 1200bp and 1249bp respectively, an EcoR I restriction site was designed at the 5' end of the upstream primer of the upper homology arm, and a BamH I restriction site was designed at the 5' end of the downstream primer of the lower homology arm. The above primers were synthesized by Beijing Huada Gene Company.

[0074] The primer sequences for amplifying the upper homology arm are as follows:

[0075] cl...

Embodiment 2

[0092] Example 2 Construction of APP serotype 7 clpP and apxIIC double gene deletion mutants

[0093] 2.1 Construction of recombinant suicide vector pUCΔapxIIC

[0094] 2.1.1 Primer design and PCR amplification of the upper and lower homology arms of the apx II C gene

[0095] According to the reported sequence of APP-7 AP76 strain (refer to the gene sequence of GenBank accession number CP001091.1), two pairs of primers were designed to amplify the upper homology arm apx II CS and the lower homology arm apx II of the apx II C gene respectively Cx, the sizes of the amplified fragments are 1412bp and 1443bp respectively, EcoR I restriction site is designed at the 5' end of the upstream primer of the upper homology arm, and a BamH I restriction site is designed at the 5' end of the downstream primer of the lower homology arm. The above primers were synthesized by Beijing Huada Gene Company.

[0096] The primer sequences for amplifying the upper homology arm are as follows:

[...

Embodiment 3

[0114] Example 3 Toxicity identification and immune protection experiment of APPΔclpPΔapx II C mutant strain

[0115] Experimental animals: SPF Balb / C female mice aged 4-6 weeks were purchased from the Experimental Animal Center of Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences.

[0116] 3.1 Virulence identification

[0117] The mice were randomly divided into two groups, 10 in each group. The specific vaccination plan is as follows:

[0118] The first group (test group): inoculated with APPΔclpPΔapx II C prepared in Example 2, diluted to the concentration (CFU) listed in Table 1, and each mouse was inoculated intraperitoneally with a dose of 0.1 ml.

[0119] The second group (control group): inoculated with Actinobacillus pleuropneumoniae CVCC265, diluted to the concentration (CFU) listed in Table 1, and each mouse was inoculated with 0.1 ml of intraperitoneal dose.

[0120] The survival of the mice is shown in Table 1.

[0121] Table 1

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a resistance marker-free porcine actinobacillus pleuropneumoniae (APP) serum type 7 double-gene defective strain, and belongs to the technical field of bacterial gene engineering. The recombinant strain APPdeltaclpPdeltaapx II C of APP is obtained by inactivating ClpP protease in the APP and a coded gene of a hemolysin activated factor Apx II C by adopting a directional homologous recombination technology, and expression of the ClpP protease and the Apx II C protein is destroyed. The obtained double-gene defective strain has lower toxicity compared with a parent strain, is safe to animals, provides an important basis for transformation of porcine contagious pleuropneumonia (PCP) vaccines and research of matched identification and diagnosis reagents, and has great significance for promoting elimination and purification of the global PCP.

Description

technical field [0001] The invention relates to a ClpP protease and ApxIIC double gene deletion strain of Actinobacillus pleuropneumoniae without resistance marker, its construction method and application, and belongs to the technical field of bacterial genetic engineering. Background technique [0002] Porcine contagious pleuropneumonia (PCP) is a highly contagious and fatal respiratory infectious disease caused by Actinobacillus pleuropneumoniae (APP). At present, the disease has been widely prevalent in countries all over the world, causing huge economic losses, and has become one of the internationally recognized important infectious diseases that endanger the modern pig industry. With the large-scale and intensive development of modern breeding industry in my country, the occurrence of this disease is in an explosive trend, and the positive rate of some pig farms has reached more than 70%, which seriously hinders the healthy development of pig farming in my country. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/20C12N15/09A61K39/02A61P31/04C12R1/01
Inventor 王春来谢芳张艳禾李刚
Owner HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI